HEALTH CATALYST, INC. (HCAT) Social Stream
HEALTH CATALYST INC (HCAT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering HCAT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 9 | $70 | $44 | $61.777 | $11.21 | 451.09% |
| 2021-11-15 | 9 | $70 | $44 | $61.625 | $11.21 | 449.73% |
| 2021-12-02 | 10 | $70 | $48 | $62.125 | $11.21 | 454.19% |
| 2021-12-08 | 9 | $70 | $48 | $61.5 | $11.21 | 448.62% |
| 2021-12-20 | 9 | $70 | $48 | $59.875 | $11.21 | 434.12% |
| 2022-03-01 | 9 | $70 | $35 | $56 | $11.21 | 399.55% |
| 2022-03-03 | 9 | $66 | $31 | $50.125 | $11.21 | 347.15% |
| 2022-03-07 | 9 | $66 | $31 | $46.625 | $11.21 | 315.92% |
| 2022-03-09 | 9 | $60 | $31 | $45.875 | $11.21 | 309.23% |
| 2022-04-01 | 10 | $60 | $28 | $45.5 | $11.21 | 305.89% |
| 2022-04-14 | 10 | $60 | $28 | $44.777 | $11.21 | 299.44% |
| 2022-05-11 | 11 | $60 | $17 | $32.583 | $11.21 | 190.66% |
| 2022-05-23 | 11 | $60 | $17 | $29.25 | $11.21 | 160.93% |
| 2022-06-28 | 11 | $60 | $17 | $28.333 | $11.21 | 152.75% |
| 2022-08-02 | 11 | $39 | $17 | $25.416 | $11.21 | 126.73% |
| 2022-08-05 | 11 | $39 | $16 | $24.166 | $11.21 | 115.58% |
| 2022-08-09 | 10 | $39 | $15 | $22.5 | $11.21 | 100.71% |
| 2022-08-10 | 9 | $39 | $15 | $20.916 | $11.21 | 86.58% |
| 2022-09-13 | 11 | $39 | $11 | $20.083 | $11.21 | 79.15% |
| 2022-09-25 | 11 | $39 | $11 | $19.833 | $11.21 | 76.92% |
| 2022-09-26 | 12 | $39 | $11 | $19.5 | $11.21 | 73.95% |
| 2022-10-25 | 12 | $39 | $9 | $18.666 | $11.21 | 66.51% |
| 2022-10-31 | 13 | $39 | $9 | $18 | $11.21 | 60.57% |
| 2022-11-10 | 13 | $39 | $8 | $17 | $11.21 | 51.65% |
| 2022-11-15 | 14 | $39 | $8 | $16.923 | $11.21 | 50.96% |
| 2023-03-01 | 14 | $39 | $8 | $16.5 | $11.21 | 47.19% |
| 2023-03-02 | 14 | $39 | $10 | $17.785 | $11.21 | 58.65% |
| 2023-03-08 | 15 | $39 | $11 | $17.428 | $11.21 | 55.47% |
| 2023-03-13 | 15 | $39 | $11 | $17.357 | $11.21 | 54.83% |
| 2023-03-24 | 15 | $39 | $11 | $17.285 | $11.21 | 54.19% |
| 2023-04-04 | 15 | $39 | $11 | $17.5 | $11.21 | 56.11% |
| 2023-04-20 | 15 | $21 | $11 | $15.857 | $11.21 | 41.45% |
| 2023-05-10 | 15 | $21 | $11 | $15.666 | $11.21 | 39.75% |
| 2023-05-15 | 15 | $21 | $11 | $15.266 | $11.21 | 36.18% |
| 2023-06-01 | 17 | $21 | $11 | $15.266 | $11.21 | 36.18% |
| 2023-08-08 | 17 | $21 | $11 | $15.312 | $11.21 | 36.59% |
| 2023-08-10 | 17 | $21 | $11 | $15 | $11.21 | 33.81% |
| 2023-08-16 | 16 | $21 | $11 | $15 | $11.21 | 33.81% |
| 2023-09-01 | 16 | $21 | $11 | $14.769 | $11.21 | 31.75% |
| 2023-10-11 | 16 | $16 | $10 | $14.166 | $11.21 | 26.37% |
| 2023-10-24 | 16 | $16 | $10 | $14.23 | $11.21 | 26.94% |
| 2023-10-30 | 16 | $16 | $8 | $13.846 | $11.21 | 23.51% |
| 2023-11-01 | 16 | $16 | $8 | $13.615 | $11.21 | 21.45% |
| 2023-11-03 | 16 | $16 | $8 | $13.307 | $11.21 | 18.71% |
| 2023-11-08 | 16 | $16 | $8 | $12.923 | $11.21 | 15.28% |
| 2023-11-09 | 16 | $16 | $8 | $12.692 | $11.21 | 13.22% |
| 2023-11-13 | 16 | $16 | $8 | $12.615 | $11.21 | 12.53% |
| 2023-12-01 | 16 | $16 | $8 | $12.23 | $11.21 | 9.1% |
| 2023-12-13 | 16 | $16 | $8 | $12 | $11.21 | 7.05% |
| 2023-12-22 | 16 | $16 | $8 | $12.076 | $11.21 | 7.73% |
The Trend in the Analyst Price Target
HCAT's average price target has moved down $42.69 over the prior 32 months.
Over the past 47 weeks, HCAT's average upside potential has been 41.6%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-24 | 15 | 39 | 11 | 17.285 | 11.55 | 49.65% |
| 2023-04-04 | 14 | 39 | 11 | 17.500 | 12.50 | 40% |
| 2023-05-15 | 15 | 21 | 11 | 15.266 | 11.11 | 37.41% |
| 2023-09-01 | 17 | 16 | 11 | 14.250 | 11.72 | 21.59% |
| 2023-11-03 | 16 | 16 | 8 | 13.307 | 7.60 | 75.09% |
HCAT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.75 | 10 | 0 | 6 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
HCAT's average broker recommendation rating worsened by 0.75 over the prior 17 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HCAT as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, HEALTH CATALYST INC's variance in analysts' estimates is lower than -5201.59% of them.
- HCAT has a higher number of analysts covering the stock than 5775.73% of stocks in the mid market cap category.
- HEALTH CATALYST INC's average analyst price target is higher than 2413.29% of stocks in the mid market cap category.
- HEALTH CATALYST INC's upside potential (average analyst target price relative to current price) is greater than 4829.13% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Business Services industry with the ratings most similar to HEALTH CATALYST INC are DOYU, EB, and HUYA.
View All Top Stocks by Price Target
What is the outlook for HCAT? Use POWR Ratings for clearer insight into price direction.